| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |